BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 15 filers reported holding BIOLINERX LTD in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $168,000 | +740.0% | 175,156 | +715.9% | 0.01% | – |
Q4 2016 | $20,000 | -88.5% | 21,469 | -85.8% | 0.00% | -100.0% |
Q3 2016 | $174,000 | +625.0% | 151,029 | +414.1% | 0.00% | – |
Q2 2016 | $24,000 | -82.6% | 29,379 | -78.3% | 0.00% | -100.0% |
Q1 2016 | $138,000 | -10.4% | 135,343 | +133.5% | 0.00% | +33.3% |
Q2 2015 | $154,000 | +148.4% | 57,957 | +98.6% | 0.00% | +200.0% |
Q1 2015 | $62,000 | +148.0% | 29,183 | +144.0% | 0.00% | – |
Q2 2014 | $25,000 | -39.0% | 11,962 | -35.8% | 0.00% | -100.0% |
Q1 2014 | $41,000 | +10.8% | 18,640 | +42.0% | 0.00% | – |
Q4 2013 | $37,000 | +54.2% | 13,129 | +22.7% | 0.00% | – |
Q3 2013 | $24,000 | – | 10,701 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Senvest Management, LLC | 3,543,300 | $2,835,000 | 0.23% |
Opaleye Management Inc. | 250,000 | $223,000 | 0.15% |
Benchmark Capital Advisors | 44,000 | $35,000 | 0.03% |
MENTA CAPITAL LLC | 98,647 | $79,000 | 0.01% |
NEXT Financial Group, Inc | 39,500 | $31,000 | 0.01% |
Cutter & CO Brokerage, Inc. | 25,000 | $20,000 | 0.01% |
Orbimed Advisors | 1,038,600 | $831,000 | 0.01% |
TWO SIGMA SECURITIES, LLC | 17,771 | $14,000 | 0.01% |
Alyeska Investment Group, L.P. | 611,947 | $490,000 | 0.01% |
A.R.T. Advisors, LLC | 25,890 | $20,000 | 0.00% |